Renz, Harald
Allen, Katrina J.
Sicherer, Scott H.
Sampson, Hugh A.
Lack, Gideon
Beyer, Kirsten
Oettgen, Hans C.
Article History
First Online: 4 January 2018
Competing interests
: S.H.S. has received funding paid to his institution for grant support from HAL Allergy and has received royalties from UpToDate. H.A.S. is a part-time employee of DBV Technologies, serving as its chief scientific officer; he has consulted for Allertein, Hycor and UCB and he owns stock options in DBV Technologies. K.B. has received grant money for research from Aimmune, Danone, DBV, DST Diagnostic, Hipp, Hycor and ThermoFisher; she has received speaker fees or honoraria for advisory boards from Aimmune, ALK, AllergoPharma, Bausch & Lomb, Danone, HAL Allergy, Meda Pharma, MedUpdate, Nestlé, Novartis and Unilever. The remaining authors declare no competing interests.